Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05428969
Title A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies (BEXMAB)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Faron Pharmaceuticals Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FIN

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06510 United States Details
UNC Lineberger Comprehensive Cancer Center RECRUITING Chapel Hill North Carolina 27599 United States Details
University of Texas, MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Helsinki University Hospital RECRUITING Helsinki 00029 Finland Details
Kuopio University Hospital RECRUITING Kuopio 70210 Finland Details
Oulu University Hospital RECRUITING Oulu 90029 Finland Details
Tampere University Hospital RECRUITING Tampere 33520 Finland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field